American Oncology Network, Inc. (AONC)

American Oncology Network Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.85	28.54	26.93	27.35	42.84
Short-Term Investments	9.79	35.39	9.85	-	-
Cash & Short-Term Investments	72.64	63.93	36.78	27.35	42.84
Cash Growth	13.63%	73.83%	34.45%	-36.15%	-
Accounts Receivable	129.23	129.15	136.1	111.23	80.42
Other Receivables	58.2	34.27	28.2	25.08	15.72
Receivables	189.63	165.03	166.1	138.12	97.92
Inventory	60.71	44.57	36.48	34.53	22.06
Prepaid Expenses	8.49	4.28	2.67	3.28	1.39
Restricted Cash	-	-	-	5	-
Total Current Assets	331.47	277.8	242.02	208.28	164.21
Property, Plant & Equipment	98.53	83.79	75.7	32.65	28.66
Long-Term Investments	-	1.75	-	-	-
Goodwill	10.9	1.05	-	-	-
Other Intangible Assets	2.48	0.18	1.23	1.11	0.48
Long-Term Deferred Tax Assets	-	2.89	-	-	0.79
Other Long-Term Assets	25.58	5.83	5.2	3.11	2.09
Total Assets	470.33	374.45	326.23	248.3	200.83

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	170.74	127.65	106.5	92.91	70.34
Accrued Expenses	20.96	17.47	9.92	14.01	7.31
Short-Term Debt	-	-	-	-	10
Current Portion of Long-Term Debt	3.74	-	-	-	10.8
Current Portion of Leases	8.48	7.88	9.6	-	-
Current Income Taxes Payable	0.73	0.97	-	-	-
Current Unearned Revenue	-	-	-	3.74	17.19
Other Current Liabilities	12.19	15.08	14.92	8.68	6.83
Total Current Liabilities	216.85	169.05	140.94	119.34	122.47
Long-Term Debt	87.12	80.64	80.3	63.69	15.7
Long-Term Leases	51.4	44.35	38.84	-	-
Other Long-Term Liabilities	6.96	9.7	4.13	5.72	3.03
Total Liabilities	362.32	303.74	264.21	188.75	141.2

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0	0	36.31	36.31	36.29
Additional Paid-In Capital	56.29	-	-	-	-
Retained Earnings	-102.17	-161.81	25.83	23.24	23.34
Treasury Stock	-0.37	-	-	-	-
Comprehensive Income & Other	0.03	0.08	-0.12	-	-
Total Common Equity	-46.22	-161.73	62.02	59.54	59.63
Minority Interest	89.24	167.45	-	-	-
Shareholders' Equity	108.01	70.71	62.02	59.54	59.63
Total Liabilities & Equity	470.33	374.45	326.23	248.3	200.83

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	150.74	132.87	128.75	63.69	36.5
Net Cash (Debt)	-78.1	-68.95	-91.97	-36.34	6.34
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-2.08	-10.31	-	-	-
Filing Date Shares Outstanding	32.09	10.61	-	-	-
Total Common Shares Outstanding	30.19	9.52	-	-	-
Working Capital	114.63	108.76	101.08	88.93	41.74
Book Value Per Share	-1.53	-16.99	-	-	-
Tangible Book Value	-59.59	-162.96	60.79	58.43	59.15
Tangible Book Value Per Share	-1.97	-17.12	-	-	-
Machinery	17.49	14.52	16.86	13.94	10.2
Construction In Progress	9.08	2.99	1.43	1.45	0.09
Leasehold Improvements	35.55	32.49	26.08	23.74	21.89

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error